The role of screening, brief intervention, and referral to treatment in the perinatal period

Wright, Tricia E.; Terplan, Mishka; Ondersma, Steven J.; Boyce, Cheryl Anne; Yonkers, Kimberly A.; Chang, Grace; Creanga, Andreea A.

doi:10.1016/j.ajog.2016.06.038

Cited by 130 publications

(114 citation statements)

References 53 publications

Supporting

Mentioning

113

Contrasting

Order By: Relevance

“…A recent report from an expert Centers for Disease Control and Prevention advisory panel recommends universal screening for substance use at the first prenatal visit, and risk stratification with brief interventions or more intensive specialty care as warranted (Wright et al, 2016). While desirable from a public health perspective, universal screening in the context of punitive state laws poses ethical and moral dilemmas for health care providers.…”

Section: Discussionmentioning

confidence: 99%

Characterization of U.S. State Laws Requiring Health Care Provider Reporting of Perinatal Substance Use

Jarlenski

Hogan

Bogen

et al. 2017

Women's Health Issues

View full text Add to dashboard Cite

Background State policies pertaining to health care provider reporting of perinatal substance use have implications for provider screening and referral behavior, patients’ care-seeking and access to prenatal substance use disorder treatment, and pregnancy and birth outcomes. Objectives To characterize specific provisions enacted in state statutes pertaining to mandates that health care providers report perinatal substance use, and to determine the proportion of births occurring in states with such laws. Methods We conducted a systematic content analysis of statutes in all U.S. states that mentioned reporting by health care providers of substance use by pregnant women or infants exposed to substances in utero; inter-rater reliability was high. We calculated the number of states, and proportion of U.S. births occurring in states, with processes for mandatory reporting of perinatal substance use to authorities, and substance use disorder treatment provision for individuals who are reported. Results Twenty states (corresponding to 31% of births) had laws requiring health care providers to report perinatal substance use to child protective authorities, and four states (18% of births) had laws requiring reporting only when a health care provider believed the substance use was associated with child maltreatment. About half of states (13) with any reporting law had a provision promoting substance use disorder treatment in the perinatal period. Conclusions Findings inform the ongoing debate about how health policies may be used to reduce the population burden of perinatal substance use.

show abstract

Section: Discussionmentioning

confidence: 99%

Characterization of U.S. State Laws Requiring Health Care Provider Reporting of Perinatal Substance Use

Jarlenski

Hogan

Bogen

et al. 2017

Women's Health Issues

View full text Add to dashboard Cite

show abstract

“…Given the frequency of both conditions in the general population, they are worth investigating in women with perinatal depression, despite the absence thus far of formal recommendations. Rare obstetric complications such as pituitary infarction,40 as well as commonplace phenomena such as dysphoric milk ejection reflex, substance misuse, and flares of pre-existing autoimmune disease can also present with symptoms of depression 414243. Within psychiatry, care should be taken to disentangle unipolar depression from bipolar disorder, psychotic presentations, and postpartum flares of generalized anxiety and obsessive-compulsive disorder.…”

Section: Personalized Treatment For Specific Clinical Characteristicsmentioning

confidence: 99%

Management of perinatal depression with non-drug interventions

Johansen

Robakis

Williams

et al. 2019

BMJ

View full text Add to dashboard Cite

Perinatal depression is a common disorder that has been associated with serious risks to mother and child. Recently, screening for depression in pregnant and postpartum women has increased, as has the development of new psychotherapy and non-drug treatment modalities. Matching patients to treatments can be challenging, and although research into personalized treatment of major depression in the general population has increased, no published guidelines focus on personalized treatment approaches to perinatal depression. In particular, guidelines on non-drug treatments are lacking. This review summarizes the evidence on personalized non-drug treatment of perinatal depression, how to incorporate patients’ preferences, novel treatments under investigation, and the potential role of biomarkers in matching patients to treatment. The review provides recommendations for future research in personalized care of perinatal depression.

show abstract

“…While inherently rewarding, parenthood also encapsulates periods of stress, which may begin prenatally and continue across the lifespan impacting the familial system [1]. Substance use has been well associated with stress-related symptomatology [20] and exposure to stress increases subjective reports of craving that correlate with activity in brain regions such as the dorsal striatum and caudate [21].…”

Section: Increased Stress Of Caregivingmentioning

confidence: 99%

“…Addiction remains a significant concern for women and their developing child during pregnancy and the postpartum period, despite numerous prevention and intervention efforts [1]. While a vast literature exists on behavioral correlates of human parenting and addiction, a contemporary approach has adopted a neurobiological perspective to understanding how caregiving may be disrupted by addiction.…”

Section: Introductionmentioning

confidence: 99%

Parenting and addiction: neurobiological insights

Rutherford

Mayes

2017

Current Opinion in Psychology

View full text Add to dashboard Cite

Addiction remains a significant public health concern that affects multiple generations within families, and in particular the early relationship between parents and their developing child. This article will discuss recent advances in our understanding of the neurobiology of parenting and addiction. Specifically, the discussion will focus on the reward-stress dysregulation model of addicted parenting, which proposes that the dysregulation of stress and reward neural circuits by addiction represents a neurobiological pathway through which to understand how caregiving may be compromised in addicted parents. Empirical research in parents and non-parents will be discussed in support of this model and critical consideration of the model and its limitations will be provided.

show abstract

The role of screening, brief intervention, and referral to treatment in the perinatal period

Cited by 130 publications

References 53 publications

Characterization of U.S. State Laws Requiring Health Care Provider Reporting of Perinatal Substance Use

Characterization of U.S. State Laws Requiring Health Care Provider Reporting of Perinatal Substance Use

Management of perinatal depression with non-drug interventions

Parenting and addiction: neurobiological insights

Contact Info

Product

Resources

About